G

Genufood Energy Enzymes Corp
OTC:GFOO

Watchlist Manager
Genufood Energy Enzymes Corp
OTC:GFOO
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $808.9

P/E

-0.1
Current
95%
Cheaper
vs 3-y average of -2.9

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
-0.1
=
Market Cap
$80.9k
/
Net Income
$-575.9k

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
-0.1
=
Market Cap
$80.9k
/
Net Income
$-575.9k

Valuation Scenarios

Genufood Energy Enzymes Corp is trading above its industry average

If P/E returns to its Industry Average (15.5), the stock would be worth $-0.01 (11 153% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-16 381%
Maximum Upside
No Upside Scenarios
Average Downside
13 767%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple -0.1 $0
0%
Industry Average 15.5 $-0.01
-11 153%
Country Average 22.9 $-0.02
-16 381%

Forward P/E
Today’s price vs future net income

Not enough data available to calculate forward P/E

Peer Comparison

All Countries
Close

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 8 489 companies
0th percentile
-0.1
Low
0 — 15.3
Typical Range
15.3 — 33.2
High
33.2 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 15.3
Median 22.9
70th Percentile 33.2
Max 1 826 183.3

Genufood Energy Enzymes Corp
Glance View

Market Cap
808.9 USD
Industry
Consumer products

Genufood Energy Enzymes Corp. is a shell company, which currently commencing no business operations. The company is headquartered in Arcadia, California. The company went IPO on 2012-06-05. The firm were a start-up company whose focus was to promote, market, distribute and export a range of enzyme products manufactured in the United States for sale for human and animal consumption in certain Asian markets, including the Association of Southeast Asian Nations (ASEAN). The firm is planning to engage in the business of distribution and sales of medical test kits in the United States. The firm has had made two investments in Hukui Biotechnology Corporation. The firm has not generated any revenue.

GFOO Intrinsic Value
Not Available
G
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett